Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical trial NCT00122317 · COMPLETED

Trial details

NCT number: NCT00122317
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Hemoglobinuria, Nocturnal

Start date: 2005-05-01
Primary completion: 2008-09-01
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.